Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Vascul Pharmacol ; 51(2-3): 182-9, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19540932

RESUMO

Rat renal arterial rings were suspended in organ chambers for isometric tension recording. The effects of propofol on the resting tone, KCl-, norepinephrine (NE)-, serotonin- and thromboxane A(2) analog U46619-induced contractions were observed. The relaxation responses to propofol on KCl-, NE- and U46619-induced contractions were assessed in the absence or presence of cyclooxygenase inhibitor, nitric oxide synthetase inhibitor or specific K(+) channel inhibitors. Propofol did not significantly affect the resting tone, but inhibited the contractions induced by KCl-, NE-, serotonin- and U46619. Propofol (1-100 microM) concentration-dependently relaxed 60 mM KCl-, 10 microM NE-, and 1 microM U46619-induced contractions with the values of RC(50) (concentration to decline the precontraction by 50%) being 18.9 microM, 70.6 microM and 12.7 microM, respectively. Propofol-induced relaxation was attenuated by indomethacin, but not by either N(G) nitro-l-arginine methyl ester (L-NAME) or any K(+) channel specific inhibitors used. The vasorelaxations induced by acetylcholine, sodium nitroprusside and amrinone were not affected by the presence of propofol. The present results indicate that propofol antagonizes provoked contractions of the arteriole and suggest that inhibition of extracellular Ca(2+) influx and synthesis of vasodilator prostanoid may be involved in propofol-induced relaxation of the arteriole.


Assuntos
Anestésicos Intravenosos/farmacologia , Anti-Hipertensivos/farmacologia , Rim/irrigação sanguínea , Propofol/farmacologia , Vasodilatação , Animais , Arteríolas/efeitos dos fármacos , Sinalização do Cálcio , Inibidores de Ciclo-Oxigenase/farmacologia , Relação Dose-Resposta a Droga , Técnicas In Vitro , Concentração Inibidora 50 , Masculino , Doadores de Óxido Nítrico/metabolismo , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Inibidores de Fosfodiesterase/farmacologia , Bloqueadores dos Canais de Potássio/farmacologia , Ratos , Ratos Wistar , Vasoconstrição/fisiologia , Vasoconstritores/farmacologia , Vasodilatação/fisiologia , Vasodilatadores/farmacologia
2.
J Hypertens ; 26(8): 1629-35, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18622242

RESUMO

Preeclampsia is a serious pathologic complication during pregnancy, and its pathogenesis remains poorly understood. Recent studies have demonstrated that autoantibodies against angiotensin II type 1A receptor (AT1-AA) are present in women with preeclampsia. However, their role in the development of hypertension in preeclamptic patients has never been previously investigated. The present study was designed to determine whether AT1-AA isolated from the sera of preeclamptic patients causes vascular constriction and, if so, to further investigate the cellular receptors that mediate their vasoactivity. Blood samples were collected from 49 pregnant women (preeclampsia = 31, control = 18) and AT1-AA was detected using enzyme-linked immunosorbent assay. Vasoconstrictive effect of purified IgG from the sera of either preeclamptic patients or normal pregnant women was determined in isolated rat thoracic aorta, arteriae cerebri media and coronary artery. Compared with normal pregnant women, frequency of AT1-AA positive samples was markedly increased in preeclamptic patients (80.7 vs. 5.6%, P < 0.01). In isolated thoracic aortic rings, middle cerebral artery and coronary artery segments, AT1-AA induced vasoconstriction in a concentration-dependent fashion (P < 0.01). The vasoconstrictive effect of AT1-AA was completely blocked by losartan, an AT1-receptor antagonist. These data demonstrate that the AT1-AA causes significant vascular constriction in large conduit vessel as well as small resistant vessels though activation of the AT1 receptor. These results suggest that overproduction of AT1-AA is a novel risk factor in pregnant women and may play a causative role in the development of hypertension and vascular injury in preeclamptic patients.


Assuntos
Autoanticorpos/sangue , Hipertensão/imunologia , Pré-Eclâmpsia/imunologia , Receptor Tipo 1 de Angiotensina/imunologia , Vasoconstrição/imunologia , Adulto , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Animais , Aorta Torácica/efeitos dos fármacos , Aorta Torácica/imunologia , Autoanticorpos/farmacologia , Relação Dose-Resposta Imunológica , Feminino , Humanos , Hipertensão/epidemiologia , Imunoglobulina G/sangue , Imunoglobulina G/farmacologia , Técnicas In Vitro , Losartan/farmacologia , Masculino , Pré-Eclâmpsia/epidemiologia , Gravidez , Ratos , Ratos Wistar , Receptor Tipo 1 de Angiotensina/metabolismo , Fatores de Risco , Vasoconstrição/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA